Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV001711473 | SCV000240373 | likely benign | not provided | 2021-02-08 | criteria provided, single submitter | clinical testing | |
Genetic Services Laboratory, |
RCV000186804 | SCV000246629 | likely benign | not specified | 2015-01-12 | criteria provided, single submitter | clinical testing | |
Invitae | RCV000694429 | SCV000822875 | uncertain significance | Familial hemiplegic migraine | 2024-01-10 | criteria provided, single submitter | clinical testing | This sequence change replaces arginine, which is basic and polar, with histidine, which is basic and polar, at codon 3 of the ATP1A2 protein (p.Arg3His). The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This variant has not been reported in the literature in individuals affected with ATP1A2-related conditions. ClinVar contains an entry for this variant (Variation ID: 204902). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt ATP1A2 protein function with a negative predictive value of 95%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
New York Genome Center | RCV001781544 | SCV002025748 | uncertain significance | Migraine, familial hemiplegic, 2 | 2020-07-06 | criteria provided, single submitter | clinical testing |